India's Sai Parenterals rises after Australian unit renews OTC supply agreement
BUZZ-India's Sai Parenterals rises after Australian unit renews OTC supply agreement ** Shares of India's Sai Parenterals SAIP.NS rise as much as 9.7% to 578.95 rupees
** Diversified pharmaceutical formulations co says Australian unit Noumed Pharmaceuticals renews OTC medicines supply agreement with a leading Australian pharmacy network for three years
** Adds agreement is valued at AUD 30 million, with expanded product portfolio
** More than 521,551 shares change hands, about 4.5x the 30-day average volume - LSEG compiled data
** Stock up 32.3% since listing on April 2, 2026
(Reporting by Payel Das in Bengaluru)
Recent news on Sai Parenteral's
See all newsIndia's Sai Parenterals rises after Australian unit renews OTC supply agreement
Brief: Sai Parenteral's Says Noumed Pharmaceuticals Renews OTC Supply Deal Worth $30 Million
India's Sai Parenterals rises after unit signs Australia supply pact
Brief: Sai Parenteral's Australian Subsidiary Renews OTC Supply Deal
Brief: Sai Parenteral's Says Unit Signs AUD 202 Million OTC Supply Agreement